P019 SUBCUTANEOUS CERTOLIZUMAB PEGOL IS EFFECTIVE IN PATIENTS WITH PRIOR INFLIXIMAB EXPOSURE, OR CONCOMITANT IMMUNOSUPPRESSANT OR GLUCOCORTICOID TREATMENT: DATA FROM PRECISE 2 | Publicación